NGEN
NervGen Pharma·NASDAQ
--
--(--)
--
--(--)
NGEN Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Financials
2026-03-31 · Financials
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2026-03-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-23
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-01-23 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-01-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-08
Form EFFECT - Notice of Effectiveness
2026-01-08 ·
Form EFFECT - Notice of Effectiveness
2026-01-07
Form CERT - Certification by an exchange approving securities for listing
2026-01-07 ·
Form CERT - Certification by an exchange approving securities for listing
2026-01-07
Form 8-A12B - Registration of securities [Section 12(b)]
2026-01-07 ·
Form 8-A12B - Registration of securities [Section 12(b)]
2026-01-07
Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
2026-01-07 ·
Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
